These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 10193828)

  • 1. Dialysis adequacy and homocyst(e)ine concentrations in peritoneal dialysis patients.
    Ducloux D; Heuzé-Lecornu L; Gibey R; Bresson-Vautrin C; Vautrin P; Chalopin JM
    Nephrol Dial Transplant; 1999 Mar; 14(3):728-31. PubMed ID: 10193828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peritoneal homocysteine clearance is inefficient in peritoneal dialysis patients.
    Johnson DW; Kay TD; Vesey DA; Isbel N; Campbell SB; Hawley CM
    Perit Dial Int; 2000; 20(6):766-71. PubMed ID: 11216572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of the number of peritonitis episodes on peritoneal membrane function].
    Jovanović D; Nesić V; Dimitrijević Z
    Srp Arh Celok Lek; 1999; 127(1-2):28-31. PubMed ID: 10377837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peritoneal dialysis adequacy and risk of death.
    Rocco M; Soucie JM; Pastan S; McClellan WM
    Kidney Int; 2000 Jul; 58(1):446-57. PubMed ID: 10886593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of haemodialysis on plasma total homocysteine concentration.
    Arnadottir M; Berg AL; Hegbrant J; Hultberg B
    Nephrol Dial Transplant; 1999 Jan; 14(1):142-6. PubMed ID: 10052494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum concentration of haptoglobin, adequacy of peritoneal dialysis, and nutrition status of patients with and without diabetes on peritoneal dialysis.
    Sucharzewska-Tomczak M; Grzegorzewska AE; Leander M
    Adv Perit Dial; 2003; 19():246-50. PubMed ID: 14763072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of recombinant human growth hormone on urea and creatinine kinetics and selected dialysis adequacy parameters in children with end-stage renal failure treated with peritoneal dialysis].
    Jedrzejowski A; Dyras P; Pańczyk-Tomaszewska M; Mizerska-Wasiak M; Roszkowska-Blaim M; Pietrzyk JA; Gałazka B
    Pol Merkur Lekarski; 2002 Sep; 13(75):191-5. PubMed ID: 12474568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adequacy and nutrition in the absence of residual renal function in peritoneal dialysis.
    Canale R; Barone RJ; Gimenez NS; Santopietro M; Ramirez L; Palliotti A; Romero P; Amado D
    Adv Perit Dial; 2001; 17():230-4. PubMed ID: 11510282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized trial of FX high flux vs standard high flux dialysis for homocysteine clearance.
    Mudge DW; Rogers R; Hollett P; Law B; Reiger K; Petrie JJ; Price L; Johnson DW; Campbell SB; Isbel NM; Sullivan M; Hawley CM
    Nephrol Dial Transplant; 2005 Oct; 20(10):2178-85. PubMed ID: 16030045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic renal replacement therapy in children: which index is best for adequacy?
    Verrina E; Brendolan A; Gusmano R; Ronco C
    Kidney Int; 1998 Nov; 54(5):1690-6. PubMed ID: 9844146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Day-to-day variability of adequacy indexes in peritoneal dialysis.
    Virga G; Amici G; Mastrosimone S; Biasio G; Stanic L; Rin GD; Bonadonna A
    Nephrol Dial Transplant; 1999 Dec; 14(12):2932-6. PubMed ID: 10570100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adequacy in dialysis: intermittent versus continuous therapies.
    Misra M; Nolph KD
    Nefrologia; 2000; 20 Suppl 3():25-32. PubMed ID: 10835874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An analysis of adequacy of dialysis in a selected population on CAPD for over 3 years: the influence of urea and creatinine kinetics.
    Selgas R; Bajo MA; Fernandez-Reyes MJ; Bosque E; Lopez-Revuelta K; Jimenez C; Borrego F; de Alvaro F
    Nephrol Dial Transplant; 1993; 8(11):1244-53. PubMed ID: 8302464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with increased plasma homocysteine in patients using an amino acid peritoneal dialysis fluid.
    Yang SY; Huang JW; Shih KY; Hsu SP; Chu PL; Chu TS; Wu KD
    Nephrol Dial Transplant; 2005 Jan; 20(1):161-6. PubMed ID: 15572386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Characteristics of hyperhomocysteinemia in dialysis patients].
    Lovcić V; Kes P; Reiner Z
    Acta Med Croatica; 2006; 60(1):21-6. PubMed ID: 16802568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of peritoneal transport rate and dialysis adequacy with inflammation in peritoneal dialysis patients.
    Fein PA; Fazil I; Rafiq MA; Schloth T; Matza B; Chattopadhyay J; Avram MM
    Adv Perit Dial; 2006; 22():2-6. PubMed ID: 16983929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peritoneal urea and creatinine clearances in continuous peritoneal dialysis patients with different types of peritoneal solute transport.
    Tzamaloukas AH; Murata GH; Piraino B; Rao P; Bernardini J; Malhotra D; Oreopoulos DG
    Kidney Int; 1998 May; 53(5):1405-11. PubMed ID: 9573559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does amino acid-based peritoneal dialysate change homocysteine metabolism in continuous ambulatory peritoneal dialysis patients?
    Chang JM; Chen HC; Hwang SJ; Tsai JC; Lai YH
    Perit Dial Int; 2003 Dec; 23 Suppl 2():S48-51. PubMed ID: 17986557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urea kinetic modelling in two groups of patients on continuous ambulatory peritoneal dialysis.
    Barton EN; Morgan AG; Burden RP
    West Indian Med J; 1997 Jun; 46(2):57-9. PubMed ID: 9260536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence, determinants, and clinical significance of hyperhomocyst(e)inaemia in renal-transplant recipients.
    Ducloux D; Ruedin C; Gibey R; Vautrin P; Bresson-Vautrin C; Rebibou JM; Chalopin JM
    Nephrol Dial Transplant; 1998 Nov; 13(11):2890-3. PubMed ID: 9829496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.